This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,634.04 firm fixed-price delivery order is for the supply of VisionBlue 0.06% syringes with a 0.5ML capacity. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive...
This federal contract award, valued at $2,451.06, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is a firm fixed-price delivery order to provide a specific pharmaceutical product, the VISIONBLUE 0.06% SYRINGE 0.5ML, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $3,268.08 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler in Park Ridge, Illinois. The contract is for the delivery of 0.5ML VISIONBLUE 0.06% syringes and has a completion date of May 13, 2024. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA's Medical Supply Chain...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,073.48 contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML. The order has a period of performance through June 30, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This contract award is a delivery order (SPE2DB25FZG04) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,691.16 firm fixed-price contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML medical supplies to support the medical needs of U.S. military healthcare facilities. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under the DLA's SPE2DB indefinite delivery vehicle, valued at up to $1,634.04 through April 2024. The contract is for the delivery of VISIONBLUE 0.06% Syringe 0.5ML, a pharmaceutical product, to support the medical supply needs of military health facilities. The contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,556.52, is for the delivery of a pharmaceutical product, specifically VisionBlue 0.06% Syringe 0.5ML. The contract has a completion date of September 8, 2023 and is a firm fixed-price delivery order. DMS Pharmaceutical Group Inc. holds a larger...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois, is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML medical supplies. The contract, valued at $1,634.04, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract has no set-aside designation and is part of DMS Pharmaceutical Group's broader prime vendor contract SPE2DB, valued up to...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The contract is for the supply of "VISIONBLUE 0.06% SYRINGE 0.5ML" medical products, with a ceiling value of $1,691.16 and a performance period through July 8, 2025. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that has secured a significant Indefinite Delivery Contract (IDC) with the DLA, valued at...
This firm-fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML, a specialized pharmaceutical product, with a ceiling value of $1,691.16. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...